Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global CRISPR and CRISPR-Associated (Cas) Genes market size is predicted to grow from US$ 2346 million in 2025 to US$ 13040 million in 2031; it is expected to grow at a CAGR of 33.1% from 2025 to 2031.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of 'spacer DNA' from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
LPI (LP Information)' newest research report, the “CRISPR and CRISPR-Associated (Cas) Genes Industry Forecast” looks at past sales and reviews total world CRISPR and CRISPR-Associated (Cas) Genes sales in 2024, providing a comprehensive analysis by region and market sector of projected CRISPR and CRISPR-Associated (Cas) Genes sales for 2025 through 2031. With CRISPR and CRISPR-Associated (Cas) Genes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRISPR and CRISPR-Associated (Cas) Genes industry.
This Insight Report provides a comprehensive analysis of the global CRISPR and CRISPR-Associated (Cas) Genes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRISPR and CRISPR-Associated (Cas) Genes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CRISPR and CRISPR-Associated (Cas) Genes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRISPR and CRISPR-Associated (Cas) Genes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRISPR and CRISPR-Associated (Cas) Genes.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR and CRISPR-Associated (Cas) Genes market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global CRISPR and CRISPR-Associated (Cas) Genes market size is predicted to grow from US$ 2346 million in 2025 to US$ 13040 million in 2031; it is expected to grow at a CAGR of 33.1% from 2025 to 2031.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of 'spacer DNA' from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
LPI (LP Information)' newest research report, the “CRISPR and CRISPR-Associated (Cas) Genes Industry Forecast” looks at past sales and reviews total world CRISPR and CRISPR-Associated (Cas) Genes sales in 2024, providing a comprehensive analysis by region and market sector of projected CRISPR and CRISPR-Associated (Cas) Genes sales for 2025 through 2031. With CRISPR and CRISPR-Associated (Cas) Genes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRISPR and CRISPR-Associated (Cas) Genes industry.
This Insight Report provides a comprehensive analysis of the global CRISPR and CRISPR-Associated (Cas) Genes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRISPR and CRISPR-Associated (Cas) Genes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CRISPR and CRISPR-Associated (Cas) Genes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRISPR and CRISPR-Associated (Cas) Genes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRISPR and CRISPR-Associated (Cas) Genes.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR and CRISPR-Associated (Cas) Genes market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Genome Editing
- Genetic engineering
- gRNA Database/Gene Librar
- CRISPR Plasmid
- Human Stem Cells
- Genetically Modified Organisms/Crops
- Cell Line Engineering
- Biotechnology Companies
- Pharmaceutical Companies
- Academic Institutes
- Research and Development Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Editas Medicine
- Caribou Biosciences
- CRISPR therapeutics
- Intellia therapeutics, Inc.
- Cellectis
- Horizon Discovery Plc
- Sigma Aldrich
- Precision Biosciences
- Genscript
- Sangamo Biosciences Inc.
- Lonza Group Limited
- Integrated DNA Technologies
- New England Biolabs
- Origene Technologies
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
2.1.2 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CRISPR and CRISPR-Associated (Cas) Genes by Country/Region (2020, 2024 & 2031)
2.2 CRISPR and CRISPR-Associated (Cas) Genes Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic engineering
2.2.3 gRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2020-2025)
2.4 CRISPR and CRISPR-Associated (Cas) Genes Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
2.5.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
3 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET SIZE BY PLAYER
3.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Player
3.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2020-2025)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Player (2020-2025)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES BY REGION
4.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Annual Revenue by Country/Region (2020-2025)
4.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2020-2025)
4.4 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2020-2025)
4.5 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2020-2025)
4.6 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
5.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
5.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025)
6.2 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes by Region (2020-2025)
8.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
8.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET FORECAST
10.1 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2026-2031)
10.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2026-2031)
10.1.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Forecast by Country (2026-2031)
10.2.1 United States Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2.2 Canada Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2.3 Mexico Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2.4 Brazil Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2026-2031)
10.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.3.2 Japan Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3.3 Korea Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3.4 Southeast Asia Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3.5 India Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3.6 Australia Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Forecast by Country (2026-2031)
10.4.1 Germany Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4.2 France Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4.3 UK Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4.4 Italy Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4.5 Russia Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2026-2031)
10.5.1 Egypt Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.5.2 South Africa Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.5.3 Israel Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.5.4 Turkey Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.6 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Type (2026-2031)
10.7 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Editas Medicine
11.2.1 Editas Medicine Company Information
11.2.2 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Editas Medicine Main Business Overview
11.2.5 Editas Medicine Latest Developments
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Information
11.3.2 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Caribou Biosciences Main Business Overview
11.3.5 Caribou Biosciences Latest Developments
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Information
11.4.2 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 CRISPR therapeutics Main Business Overview
11.4.5 CRISPR therapeutics Latest Developments
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Information
11.5.2 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Intellia therapeutics, Inc. Main Business Overview
11.5.5 Intellia therapeutics, Inc. Latest Developments
11.6 Cellectis
11.6.1 Cellectis Company Information
11.6.2 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Cellectis Main Business Overview
11.6.5 Cellectis Latest Developments
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Information
11.7.2 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Horizon Discovery Plc Main Business Overview
11.7.5 Horizon Discovery Plc Latest Developments
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Information
11.8.2 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sigma Aldrich Main Business Overview
11.8.5 Sigma Aldrich Latest Developments
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Information
11.9.2 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Precision Biosciences Main Business Overview
11.9.5 Precision Biosciences Latest Developments
11.10 Genscript
11.10.1 Genscript Company Information
11.10.2 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Genscript Main Business Overview
11.10.5 Genscript Latest Developments
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Information
11.11.2 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Sangamo Biosciences Inc. Main Business Overview
11.11.5 Sangamo Biosciences Inc. Latest Developments
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Information
11.12.2 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Lonza Group Limited Main Business Overview
11.12.5 Lonza Group Limited Latest Developments
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Information
11.13.2 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Integrated DNA Technologies Main Business Overview
11.13.5 Integrated DNA Technologies Latest Developments
11.14 New England Biolabs
11.14.1 New England Biolabs Company Information
11.14.2 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 New England Biolabs Main Business Overview
11.14.5 New England Biolabs Latest Developments
11.15 Origene Technologies
11.15.1 Origene Technologies Company Information
11.15.2 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Origene Technologies Main Business Overview
11.15.5 Origene Technologies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CRISPR and CRISPR-Associated (Cas) Genes Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Genome Editing
Table 4. Major Players of Genetic engineering
Table 5. Major Players of gRNA Database/Gene Librar
Table 6. Major Players of CRISPR Plasmid
Table 7. Major Players of Human Stem Cells
Table 8. Major Players of Genetically Modified Organisms/Crops
Table 9. Major Players of Cell Line Engineering
Table 10. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Table 13. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2020-2025) & ($ millions)
Table 17. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Player (2020-2025)
Table 18. CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Products Offered
Table 19. CRISPR and CRISPR-Associated (Cas) Genes Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & ($ millions)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2020-2025)
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country/Region (2020-2025) & ($ millions)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country/Region (2020-2025)
Table 26. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & ($ millions)
Table 27. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country (2020-2025)
Table 28. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 29. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Table 30. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 31. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Table 32. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & ($ millions)
Table 33. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2020-2025)
Table 34. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 35. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 36. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & ($ millions)
Table 37. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country (2020-2025)
Table 38. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 40. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & ($ millions)
Table 41. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 42. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of CRISPR and CRISPR-Associated (Cas) Genes
Table 44. Key Market Challenges & Risks of CRISPR and CRISPR-Associated (Cas) Genes
Table 45. Key IndustryTrends of CRISPR and CRISPR-Associated (Cas) Genes
Table 46. Global CRISPR and CRISPR-Associated (Cas) Genes Market SizeForecast by Region (2026-2031) & ($ millions)
Table 47. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market ShareForecast by Region (2026-2031)
Table 48. Global CRISPR and CRISPR-Associated (Cas) Genes Market SizeForecast byType (2026-2031) & ($ millions)
Table 49. Global CRISPR and CRISPR-Associated (Cas) Genes Market SizeForecast by Application (2026-2031) & ($ millions)
Table 50.ThermoFisher Scientific Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 51.ThermoFisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 52.ThermoFisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53.ThermoFisher Scientific Main Business
Table 54.ThermoFisher Scientific Latest Developments
Table 55. Editas Medicine Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 56. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 57. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Editas Medicine Main Business
Table 59. Editas Medicine Latest Developments
Table 60. Caribou Biosciences Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 61. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 62. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Caribou Biosciences Main Business
Table 64. Caribou Biosciences Latest Developments
Table 65. CRISPR therapeutics Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 66. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 67. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. CRISPR therapeutics Main Business
Table 69. CRISPR therapeutics Latest Developments
Table 70. Intellia therapeutics, Inc. Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 71. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 72. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Intellia therapeutics, Inc. Main Business
Table 74. Intellia therapeutics, Inc. Latest Developments
Table 75. Cellectis Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 76. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 77. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Cellectis Main Business
Table 79. Cellectis Latest Developments
Table 80. Horizon Discovery Plc Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 81. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 82. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Horizon Discovery Plc Main Business
Table 84. Horizon Discovery Plc Latest Developments
Table 85. Sigma Aldrich Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 86. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 87. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sigma Aldrich Main Business
Table 89. Sigma Aldrich Latest Developments
Table 90. Precision Biosciences Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 91. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 92. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Precision Biosciences Main Business
Table 94. Precision Biosciences Latest Developments
Table 95. Genscript Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 96. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 97. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Genscript Main Business
Table 99. Genscript Latest Developments
Table 100. Sangamo Biosciences Inc. Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 101. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 102. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Sangamo Biosciences Inc. Main Business
Table 104. Sangamo Biosciences Inc. Latest Developments
Table 105. Lonza Group Limited Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 106. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 107. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Lonza Group Limited Main Business
Table 109. Lonza Group Limited Latest Developments
Table 110. Integrated DNATechnologies Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 111. Integrated DNATechnologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 112. Integrated DNATechnologies CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Integrated DNATechnologies Main Business
Table 114. Integrated DNATechnologies Latest Developments
Table 115. New England Biolabs Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 116. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 117. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. New England Biolabs Main Business
Table 119. New England Biolabs Latest Developments
Table 120. OrigeneTechnologies Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 121. OrigeneTechnologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 122. OrigeneTechnologies CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. OrigeneTechnologies Main Business
Table 124. OrigeneTechnologies Latest Developments
LIST OFFIGURES
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CRISPR and CRISPR-Associated (Cas) Genes Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country/Region (2024)
Figure 8. CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType in 2024
Figure 10. CRISPR and CRISPR-Associated (Cas) Genes in Biotechnology Companies
Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Biotechnology Companies (2020-2025) & ($ millions)
Figure 12. CRISPR and CRISPR-Associated (Cas) Genes in Pharmaceutical Companies
Figure 13. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Pharmaceutical Companies (2020-2025) & ($ millions)
Figure 14. CRISPR and CRISPR-Associated (Cas) Genes in Academic Institutes
Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Academic Institutes (2020-2025) & ($ millions)
Figure 16. CRISPR and CRISPR-Associated (Cas) Genes in Research and Development Institutes
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Research and Development Institutes (2020-2025) & ($ millions)
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2024
Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Player in 2024
Figure 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2020-2025)
Figure 21. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size 2020-2025 ($ millions)
Figure 22. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size 2020-2025 ($ millions)
Figure 23. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2020-2025 ($ millions)
Figure 25. Americas CRISPR and CRISPR-Associated (Cas) Genes Value Market Share by Country in 2024
Figure 26. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region in 2024
Figure 31. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Figure 32. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Figure 33. China CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 37. India CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country in 2024
Figure 40. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Figure 41. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Figure 42. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 43.France CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 44. UK CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Figure 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Figure 50. Egypt CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 53.Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 56. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 57. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 59. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 60. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 61. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 62. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 63. China CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 64. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 65. Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 67. India CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 68. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 69. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 70.France CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 71. UK CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 72. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 73. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 74. Egypt CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 75. South Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 76. Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 77.Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 78. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market ShareForecast byType (2026-2031)
Figure 79. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market ShareForecast by Application (2026-2031)
Figure 80. GCC Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size (2020-2031)
2.1.2 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for CRISPR and CRISPR-Associated (Cas) Genes by Country/Region (2020, 2024 & 2031)
2.2 CRISPR and CRISPR-Associated (Cas) Genes Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic engineering
2.2.3 gRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2020-2025)
2.4 CRISPR and CRISPR-Associated (Cas) Genes Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
2.5.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
3 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET SIZE BY PLAYER
3.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Player
3.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2020-2025)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Player (2020-2025)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR AND CRISPR-ASSOCIATED (CAS) GENES BY REGION
4.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025)
4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Annual Revenue by Country/Region (2020-2025)
4.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2020-2025)
4.4 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2020-2025)
4.5 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2020-2025)
4.6 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
5.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
5.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025)
6.2 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
6.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes by Region (2020-2025)
8.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2020-2025)
8.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CRISPR AND CRISPR-ASSOCIATED (CAS) GENES MARKET FORECAST
10.1 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2026-2031)
10.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2026-2031)
10.1.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Forecast by Country (2026-2031)
10.2.1 United States Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2.2 Canada Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2.3 Mexico Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2.4 Brazil Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2026-2031)
10.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.3.2 Japan Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3.3 Korea Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3.4 Southeast Asia Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3.5 India Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.3.6 Australia Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Forecast by Country (2026-2031)
10.4.1 Germany Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4.2 France Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4.3 UK Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4.4 Italy Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.4.5 Russia Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2026-2031)
10.5.1 Egypt Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.5.2 South Africa Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.5.3 Israel Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.5.4 Turkey Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.6 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Type (2026-2031)
10.7 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Application (2026-2031)
10.7.1 GCC Countries Market CRISPR and CRISPR-Associated (Cas) Genes Forecast
11 KEY PLAYERS ANALYSIS
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Editas Medicine
11.2.1 Editas Medicine Company Information
11.2.2 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Editas Medicine Main Business Overview
11.2.5 Editas Medicine Latest Developments
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Information
11.3.2 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Caribou Biosciences Main Business Overview
11.3.5 Caribou Biosciences Latest Developments
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Information
11.4.2 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 CRISPR therapeutics Main Business Overview
11.4.5 CRISPR therapeutics Latest Developments
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Information
11.5.2 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Intellia therapeutics, Inc. Main Business Overview
11.5.5 Intellia therapeutics, Inc. Latest Developments
11.6 Cellectis
11.6.1 Cellectis Company Information
11.6.2 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Cellectis Main Business Overview
11.6.5 Cellectis Latest Developments
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Information
11.7.2 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Horizon Discovery Plc Main Business Overview
11.7.5 Horizon Discovery Plc Latest Developments
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Information
11.8.2 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Sigma Aldrich Main Business Overview
11.8.5 Sigma Aldrich Latest Developments
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Information
11.9.2 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Precision Biosciences Main Business Overview
11.9.5 Precision Biosciences Latest Developments
11.10 Genscript
11.10.1 Genscript Company Information
11.10.2 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Genscript Main Business Overview
11.10.5 Genscript Latest Developments
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Information
11.11.2 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Sangamo Biosciences Inc. Main Business Overview
11.11.5 Sangamo Biosciences Inc. Latest Developments
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Information
11.12.2 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Lonza Group Limited Main Business Overview
11.12.5 Lonza Group Limited Latest Developments
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Information
11.13.2 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Integrated DNA Technologies Main Business Overview
11.13.5 Integrated DNA Technologies Latest Developments
11.14 New England Biolabs
11.14.1 New England Biolabs Company Information
11.14.2 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 New England Biolabs Main Business Overview
11.14.5 New England Biolabs Latest Developments
11.15 Origene Technologies
11.15.1 Origene Technologies Company Information
11.15.2 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Origene Technologies Main Business Overview
11.15.5 Origene Technologies Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. CRISPR and CRISPR-Associated (Cas) Genes Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Genome Editing
Table 4. Major Players of Genetic engineering
Table 5. Major Players of gRNA Database/Gene Librar
Table 6. Major Players of CRISPR Plasmid
Table 7. Major Players of Human Stem Cells
Table 8. Major Players of Genetically Modified Organisms/Crops
Table 9. Major Players of Cell Line Engineering
Table 10. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Table 13. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2020-2025) & ($ millions)
Table 17. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Player (2020-2025)
Table 18. CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Products Offered
Table 19. CRISPR and CRISPR-Associated (Cas) Genes Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & ($ millions)
Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2020-2025)
Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Country/Region (2020-2025) & ($ millions)
Table 25. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Country/Region (2020-2025)
Table 26. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & ($ millions)
Table 27. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country (2020-2025)
Table 28. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 29. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Table 30. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 31. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Table 32. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & ($ millions)
Table 33. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2020-2025)
Table 34. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 35. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 36. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2020-2025) & ($ millions)
Table 37. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country (2020-2025)
Table 38. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 40. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2020-2025) & ($ millions)
Table 41. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size byType (2020-2025) & ($ millions)
Table 42. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2020-2025) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of CRISPR and CRISPR-Associated (Cas) Genes
Table 44. Key Market Challenges & Risks of CRISPR and CRISPR-Associated (Cas) Genes
Table 45. Key IndustryTrends of CRISPR and CRISPR-Associated (Cas) Genes
Table 46. Global CRISPR and CRISPR-Associated (Cas) Genes Market SizeForecast by Region (2026-2031) & ($ millions)
Table 47. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market ShareForecast by Region (2026-2031)
Table 48. Global CRISPR and CRISPR-Associated (Cas) Genes Market SizeForecast byType (2026-2031) & ($ millions)
Table 49. Global CRISPR and CRISPR-Associated (Cas) Genes Market SizeForecast by Application (2026-2031) & ($ millions)
Table 50.ThermoFisher Scientific Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 51.ThermoFisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 52.ThermoFisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53.ThermoFisher Scientific Main Business
Table 54.ThermoFisher Scientific Latest Developments
Table 55. Editas Medicine Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 56. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 57. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Editas Medicine Main Business
Table 59. Editas Medicine Latest Developments
Table 60. Caribou Biosciences Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 61. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 62. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Caribou Biosciences Main Business
Table 64. Caribou Biosciences Latest Developments
Table 65. CRISPR therapeutics Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 66. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 67. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. CRISPR therapeutics Main Business
Table 69. CRISPR therapeutics Latest Developments
Table 70. Intellia therapeutics, Inc. Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 71. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 72. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Intellia therapeutics, Inc. Main Business
Table 74. Intellia therapeutics, Inc. Latest Developments
Table 75. Cellectis Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 76. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 77. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Cellectis Main Business
Table 79. Cellectis Latest Developments
Table 80. Horizon Discovery Plc Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 81. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 82. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Horizon Discovery Plc Main Business
Table 84. Horizon Discovery Plc Latest Developments
Table 85. Sigma Aldrich Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 86. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 87. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Sigma Aldrich Main Business
Table 89. Sigma Aldrich Latest Developments
Table 90. Precision Biosciences Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 91. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 92. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Precision Biosciences Main Business
Table 94. Precision Biosciences Latest Developments
Table 95. Genscript Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 96. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 97. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Genscript Main Business
Table 99. Genscript Latest Developments
Table 100. Sangamo Biosciences Inc. Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 101. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 102. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Sangamo Biosciences Inc. Main Business
Table 104. Sangamo Biosciences Inc. Latest Developments
Table 105. Lonza Group Limited Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 106. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 107. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Lonza Group Limited Main Business
Table 109. Lonza Group Limited Latest Developments
Table 110. Integrated DNATechnologies Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 111. Integrated DNATechnologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 112. Integrated DNATechnologies CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Integrated DNATechnologies Main Business
Table 114. Integrated DNATechnologies Latest Developments
Table 115. New England Biolabs Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 116. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 117. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. New England Biolabs Main Business
Table 119. New England Biolabs Latest Developments
Table 120. OrigeneTechnologies Details, CompanyType, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 121. OrigeneTechnologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 122. OrigeneTechnologies CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. OrigeneTechnologies Main Business
Table 124. OrigeneTechnologies Latest Developments
LIST OFFIGURES
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. CRISPR and CRISPR-Associated (Cas) Genes Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country/Region (2024)
Figure 8. CRISPR and CRISPR-Associated (Cas) Genes Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType in 2024
Figure 10. CRISPR and CRISPR-Associated (Cas) Genes in Biotechnology Companies
Figure 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Biotechnology Companies (2020-2025) & ($ millions)
Figure 12. CRISPR and CRISPR-Associated (Cas) Genes in Pharmaceutical Companies
Figure 13. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Pharmaceutical Companies (2020-2025) & ($ millions)
Figure 14. CRISPR and CRISPR-Associated (Cas) Genes in Academic Institutes
Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Academic Institutes (2020-2025) & ($ millions)
Figure 16. CRISPR and CRISPR-Associated (Cas) Genes in Research and Development Institutes
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Research and Development Institutes (2020-2025) & ($ millions)
Figure 18. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2024
Figure 19. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Player in 2024
Figure 20. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2020-2025)
Figure 21. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size 2020-2025 ($ millions)
Figure 22. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size 2020-2025 ($ millions)
Figure 23. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2020-2025 ($ millions)
Figure 25. Americas CRISPR and CRISPR-Associated (Cas) Genes Value Market Share by Country in 2024
Figure 26. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region in 2024
Figure 31. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Figure 32. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Figure 33. China CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 37. India CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country in 2024
Figure 40. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Figure 41. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Figure 42. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 43.France CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 44. UK CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share byType (2020-2025)
Figure 49. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2020-2025)
Figure 50. Egypt CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 53.Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 56. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 57. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 59. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 60. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 61. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 62. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 63. China CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 64. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 65. Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 67. India CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 68. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 69. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 70.France CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 71. UK CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 72. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 73. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 74. Egypt CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 75. South Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 76. Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 77.Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
Figure 78. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market ShareForecast byType (2026-2031)
Figure 79. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market ShareForecast by Application (2026-2031)
Figure 80. GCC Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size 2026-2031 ($ millions)
More Publications
Global Radiation Protective Limb Shields Market Growth 2024-2030
US$ 3,660.00
September 2024
92 pages
Global Hemoglobin A1C Testing in Veterinary Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
June 2024
78 pages
Global Silt Lamp Imaging Systems Market Growth 2023-2029
US$ 3,660.00
February 2023
100 pages
Global Hemoglobinopathy Treatment Drug Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
131 pages
